Meditation Has Been Studied for Decades. What Has Science Actually Found?

There is something strange about the position meditation now occupies. Few practices have accumulated so much peer-reviewed research and so large a halo of claims at the same time. Depending on which corner of the internet you land in, meditation may supposedly ease anxiety, prevent depression, sharpen attention, deepen sleep, dial down chronic pain, lower blood pressure, quiet inflammation, strengthen immunity, rewire the brain, and even slow the biological clock inside your cells.

The question of whether meditation has been studied is no longer interesting. It clearly has — by researchers publishing in the journals that decide what counts as evidence in medicine, in trials that have enrolled tens of thousands of people, and in meta-analyses that pool decades of work into single, poolable numbers. The more interesting question is what survived once researchers began aggregating all of that work, comparing meditation against genuine alternatives, and checking which findings replicate and which quietly evaporate under scrutiny.

The honest answer is not a single verdict. It is a gradient. Some outcomes are backed by evidence that a skeptical clinician would find reasonably convincing. Others look promising but depend heavily on the population, the comparison group, and the specific practice involved. And some of the most widely repeated claims — the ones about meditation "changing your brain" or "slowing aging" — rest on a much thinner and more contested foundation than the wellness industry lets on.

What Holds Up Reasonably Well

The single most influential piece of evidence in this field is a 2014 systematic review and meta-analysis published in JAMA Internal Medicine, led by Madhav Goyal and colleagues at Johns Hopkins [1]. The review pooled 47 randomized trials involving roughly 3,500 participants and required every included trial to have some form of active comparison group — no trial comparing meditation only to an untreated waitlist qualified. Within that pool, the authors distinguished two kinds of comparator: nonspecific active controls, where participants received attention and support but no specific therapeutic technique (an education class or discussion group, for instance), and specific active controls, where participants received an established treatment such as exercise, cognitive behavioral therapy, or progressive muscle relaxation.

Against nonspecific active controls, the review found moderate-quality evidence of small-to-moderate improvements in anxiety and depression symptoms — effects that persisted, somewhat diminished, out to three to six months — alongside a similar improvement in pain, plus low-quality evidence for reduced general stress and distress. It found insufficient or no evidence of benefit for attention, substance use, eating habits, sleep, or weight. Against the specific active controls — exercise, cognitive behavioral therapy, progressive muscle relaxation — the review found low-quality evidence of no effect, or simply insufficient evidence either way, that meditation outperformed them.

That distinction matters more than it might seem. A treatment can look genuinely helpful against a nonspecific comparator — people getting attention and encouragement but no real technique — while its advantage narrows or disappears once the comparison is another established, specific treatment. Goyal and colleagues were explicit that their more favorable numbers came from the nonspecific-control comparisons; the picture against specific active treatments was considerably weaker.

A broader synthesis published in 2022 in Perspectives on Psychological Science, by Simon Goldberg and colleagues at the University of Wisconsin–Madison, extended this picture. The team systematically reviewed 44 meta-analyses covering 336 randomized trials and more than 30,000 participants, deliberately separating results by whether mindfulness-based interventions were compared against passive or nonspecific controls versus active, specific ones [2]. The pattern echoed Goyal's: mindfulness programs showed more consistent effects against passive or nonspecific comparators across a range of populations and problems, while those advantages became smaller and less consistent once the comparison group was itself receiving a credible, specific intervention. This is not a reason to dismiss the psychological evidence. It is a reason to be precise about what "meditation works" actually means: the evidence is generally stronger against passive or nonspecific comparators, and it thins out — without becoming demonstrated equivalence or inferiority in either direction — once the comparison is another credible, established treatment.

Chronic pain sits in a similar place. A 2017 meta-analysis in the Annals of Behavioral Medicine, led by RAND Corporation researcher Lara Hilton, pooled 30 randomized trials of mindfulness meditation for chronic pain [3]. The review found a small but real improvement in pain symptoms, graded as low-quality evidence under the GRADE framework, with additional signals of improvement in depression and quality of life. Small and low-quality does not mean useless — it means the honest label for this benefit is modest, not transformative, and that better trials are still needed to firm up the size of the effect.

Sleep: Promising, But Context Matters

Sleep is where the evidence gets more interesting precisely because it resists a simple headline. A frequently cited 2015 randomized trial in JAMA Internal Medicine, led by David Black at USC, compared a six-week mindfulness meditation program against a structured sleep hygiene education program in 49 older adults with moderate sleep disturbances [4]. The meditation group showed greater improvement in sleep quality and daytime impairment immediately after the program — a genuinely useful finding, though it is worth remembering this was one trial, in a relatively small and specific population, comparing meditation to one particular alternative.

A larger 2019 systematic review and meta-analysis in the Annals of the New York Academy of Sciences, led by Heather Rusch at the National Institutes of Health, pooled 18 trials and 1,654 participants [5]. According to the National Center for Complementary and Integrative Health's summary of that review, mindfulness meditation improved sleep quality more than education-based or passive comparisons — but showed no clear advantage over established, specific sleep treatments such as cognitive behavioral therapy for insomnia or exercise [6]. That is the crucial distinction: meditation may help people sleep better than doing nothing, but nothing in the current evidence suggests it should replace the treatments with the strongest track record for insomnia specifically.

Cognition: A Mixed and Domain-Specific Picture

The claim that meditation "makes you smarter" or sharpens the mind wholesale does not survive contact with the largest study on the subject. A 2024 meta-analysis in Health Psychology Review, led by Nur Hani Zainal and Michelle Newman, pooled 111 randomized controlled trials and more than 9,500 participants examining fifteen distinct cognitive subdomains [7]. Some domains showed real improvement, including global cognition and measures of sustained attention, and the review's own moderator analysis found that instructor-led, in-person programs produced larger effects than self-guided programs specifically on global cognition, sustained attention accuracy, and subjective cognitive functioning. But the same analysis found no meaningful effect on executive functioning speed, verbal fluency, processing speed, or episodic memory. In other words, "meditation improves cognition" collapses several genuinely different questions into one sentence. Some cognitive domains respond; others, on the current evidence, simply do not.

Where the Biological Claims Get Considerably Less Certain

This is the part of the meditation story that popular coverage handles worst, because it is genuinely counterintuitive: the psychological benefits and the biological benefits do not necessarily travel together.

A pilot study published in 2022 in Brain, Behavior, & Immunity – Health offers a useful, unglamorous illustration. Researchers at the Cleveland Clinic randomized stressed nurses to either a six-week, low-time-commitment online mindfulness program or an active control of listening to relaxing music [8]. Perceived stress dropped in both groups, with a somewhat delayed improvement in the mindfulness arm. But when the researchers looked at gene expression, inflammatory cytokines, telomerase activity in blood cells, and cortisol rhythms, they found no measurable change from the program. It is one modestly sized trial of one low-dose format, and its authors were appropriately cautious about generalizing — but it is a clean demonstration that subjective improvement and biomarker change can decouple.

The clearest and largest illustration of that decoupling comes from a much bigger, much more recent source: a 2026 systematic review and meta-analysis in Health Psychology Review, led by Mahesh Kumar Khanal and colleagues, examining meditation's effects on employees' mental health and cardiometabolic risk markers [9]. This is a substantial piece of evidence — 132 randomized controlled trials, 145 intervention groups, and 23,080 participants, most involving mindfulness or Transcendental Meditation programs delivered to healthcare workers and educators, largely in the United States. Within this employee-specific evidence base, the psychological results followed a familiar pattern: meditation significantly reduced perceived stress, general distress, job-specific stress, anxiety, and depression, while improving well-being, resilience, and sleep, with small-to-moderate effect sizes that were mostly sustained at follow-up.

The physiological results told a different story. Across this large pool of workplace trials, meditation interventions showed no statistically significant effect on blood pressure, cortisol levels, heart rate variability, or inflammatory markers. This does not mean meditation has zero physiological footprint in every population or study design — smaller, more tightly controlled trials elsewhere have sometimes found narrower physiological effects. But within this particular, large, employee-focused synthesis, the biological claims that circulate most widely in popular coverage — that meditation reliably lowers blood pressure or calms the stress hormone system — showed up as considerably less secure than the psychological claims sitting right next to them in the same dataset.

Telomeres and the Trouble With "Slows Aging"

Few claims travel further from their evidence than the idea that meditation "slows aging" at the cellular level. The claim traces back to research on telomeres — the protective caps at the ends of chromosomes that shorten with cell division — and telomerase, the enzyme that helps maintain them.

The most comprehensive synthesis to date is a 2023 meta-analysis in the journal Mindfulness, by Lukas Bossert and colleagues at the University of Vienna, pooling 25 studies and just over 2,000 participants [10]. The team found small-to-medium average effects of mindfulness-based interventions on both telomere length and telomerase activity. But the paper's own authors flagged something important: those effect sizes were substantially influenced by risk of bias in the underlying studies. When bias risk was accounted for, the strength of the finding weakened considerably. That is a textbook case of why a statistically significant meta-analytic effect is not the same thing as settled science. It is a signal worth taking seriously and investigating further — not a green light to describe meditation as something that measurably reverses or halts biological aging.

Brain Structure: A Cautionary Tale, Not a Verdict

Neuroscience coverage of meditation often leans on a single, dramatic kind of evidence: brain scans showing structural change. Readers deserve to know that one of the more widely cited papers in this exact category — a 2023 anatomical likelihood meta-analysis in Scientific Reports, examining structural brain changes across eleven mindfulness trials — was retracted in 2025 [11]. The retraction notice identifies the exclusion of four null-finding studies — together representing roughly 40 percent of the pooled participants — as the central problem, alongside the inclusion of other studies drawn from narrow, nonrepresentative populations. Because those null-finding studies were left out, the notice states, the analysis was not designed to test the question it claimed to answer, and its conclusions are not supported.

This does not mean meditation neuroscience as a field is untrustworthy, and it does not mean every finding about brain structure and meditation is wrong. It means that claims about "meditation rewiring your brain," built on any single meta-analysis, deserve the same scrutiny any surprising biological claim deserves — because this is precisely the kind of spectacular result that turned out not to hold up.

The Part Wellness Marketing Leaves Out: Adverse Effects

An intervention with real average benefits can still cause real harm in a minority of people, and meditation is not an exception to that pattern. A 2020 systematic review in Acta Psychiatrica Scandinavica, led by Miguel Farias at Coventry University, examined 83 studies covering 6,703 participants who had undertaken some form of meditation practice [12]. Fifty-five of those studies — about two-thirds — reported at least one adverse event. The most commonly reported categories were anxiety and depression, followed by unusual cognitive experiences.

The National Center for Complementary and Integrative Health, summarizing this and related research, puts a rough number on it: across the pooled studies, about 8 percent of participants reported some negative effect from meditation practice — a rate the agency notes is roughly comparable to rates reported for psychological therapies generally [6]. Within that same review, a narrower subgroup analysis of randomized trials comparing mindfulness-based stress reduction specifically against wait-list or no-treatment control arms found meditation was not more likely to produce a reported adverse event than receiving no treatment. It is worth flagging that this is not the final word on the question: a separate analysis by Matthew Hirshberg and colleagues, using a large observational MBSR dataset, argued that standard reporting methods may be underestimating harm rates rather than overestimating them [13] — a reminder that the adverse-effects literature is itself still unsettled, not a solved problem. Put together, this is a genuinely useful, non-alarmist picture: adverse experiences are neither vanishingly rare nor evidence that meditation is uniquely dangerous. They are a documented part of the meditation literature, and they deserve to be mentioned in the same breath as the benefits rather than omitted from the conversation entirely.

Meditation Is Not One Thing

A recurring problem across all of this research is linguistic: "meditation" gets used as though it names a single standardized intervention, when it names a family of quite different practices. A finding about mindfulness-based cognitive therapy for people with three or more episodes of depression does not automatically apply to ten unguided minutes with a phone app. A result involving Transcendental Meditation's mantra-based technique does not automatically describe mindfulness. A study of monks with tens of thousands of hours of practice does not describe what happens to a beginner in week two. Most of the evidence reviewed above concerns structured programs — typically Mindfulness-Based Stress Reduction, related mindfulness protocols, or Transcendental Meditation — delivered over several weeks with a trained instructor. That is a meaningfully narrower category than "meditation" as a cultural umbrella term, and conflating the two is where a great deal of the exaggeration in popular coverage originates.

What the Evidence Actually Permits Us to Say

Laid end to end, the research suggests something more interesting than either "meditation works" or "meditation doesn't work." It suggests a hierarchy of confidence that tracks, almost too neatly, the modesty of the claim being made. The evidence is strongest exactly where the claims are least spectacular: small-to-moderate improvements in anxiety and depression symptoms, a real but modest dent in chronic pain, selective — not universal — cognitive benefits, and sleep improvements that hold up against weak comparisons but not against established treatments. The evidence gets progressively less secure as the claims get more biologically dramatic: biological signals that become considerably less consistent in larger syntheses — including a recent workplace meta-analysis that found no significant pooled effect on blood pressure, cortisol, heart rate variability, or inflammation — a telomere effect that shrinks once risk of bias is accounted for, and a brain-structural claim that had to be formally withdrawn from the scientific record.

None of this makes meditation a disappointment. Decades of trials, however imperfect, have identified real psychological effects that many other popular self-help interventions cannot claim. But those decades of research also drew a fairly precise boundary around what can honestly be said — and the most scientifically mature reading of that boundary is neither dismissal nor enthusiasm. It is simply paying attention to where the evidence actually is, and where it still, despite everything, is not.

References

1. Goyal, M., Singh, S., Sibinga, E. M. S., Gould, N. F., Rowland-Seymour, A., Sharma, R., Berger, Z., Sleicher, D., Maron, D. D., Shihab, H. M., Ranasinghe, P. D., Linn, S., Saha, S., Bass, E. B., & Haythornthwaite, J. A. (2014). Meditation programs for psychological stress and well-being: A systematic review and meta-analysis. JAMA Internal Medicine, 174(3), 357–368. https://doi.org/10.1001/jamainternmed.2013.13018

2. Goldberg, S. B., Riordan, K. M., Sun, S., & Davidson, R. J. (2022). The empirical status of mindfulness-based interventions: A systematic review of 44 meta-analyses of randomized controlled trials. Perspectives on Psychological Science, 17(1), 108–130. https://doi.org/10.1177/1745691620968771

3. Hilton, L., Hempel, S., Ewing, B. A., Apaydin, E., Xenakis, L., Newberry, S., Colaiaco, B., Maher, A. R., Shanman, R. M., Sorbero, M. E., & Maglione, M. A. (2017). Mindfulness meditation for chronic pain: Systematic review and meta-analysis. Annals of Behavioral Medicine, 51(2), 199–213. https://doi.org/10.1007/s12160-016-9844-2

4. Black, D. S., O'Reilly, G. A., Olmstead, R., Breen, E. C., & Irwin, M. R. (2015). Mindfulness meditation and improvement in sleep quality and daytime impairment among older adults with sleep disturbances: A randomized clinical trial. JAMA Internal Medicine, 175(4), 494–501. https://doi.org/10.1001/jamainternmed.2014.8081

5. Rusch, H. L., Rosario, M., Levison, L. M., Olivera, A., Livingston, W. S., Wu, T., & Gill, J. M. (2019). The effect of mindfulness meditation on sleep quality: A systematic review and meta-analysis of randomized controlled trials. Annals of the New York Academy of Sciences, 1445(1), 5–16. https://doi.org/10.1111/nyas.13996

6. National Center for Complementary and Integrative Health. (2022). Meditation and mindfulness: Effectiveness and safety. National Institutes of Health. https://www.nccih.nih.gov/health/meditation-and-mindfulness-effectiveness-and-safety

7. Zainal, N. H., & Newman, M. G. (2024). Mindfulness enhances cognitive functioning: A meta-analysis of 111 randomized controlled trials. Health Psychology Review, 18(2), 369–395. https://doi.org/10.1080/17437199.2023.2248222

8. Graham, B., Jin, Y., Bazeley, P., Husni, E., & Calabrese, L. H. (2022). Online, low-volume meditation does not alter immune-related biomarkers. Brain, Behavior, & Immunity – Health, 26, 100531. https://doi.org/10.1016/j.bbih.2022.100531

9. Khanal, M. K., et al. (2026). Meditation and workplace health: A systematic review and meta-analysis of mental and cardiometabolic outcomes among employees. Health Psychology Review, 20(1). https://doi.org/10.1080/17437199.2026.2652892

10. Bossert, L., Arzberger, K., Dorok, F., Kern, J., Stickler, C., Wunderlich, M., & Tran, U. S. (2023). The effects of mindfulness-based interventions on telomere length and telomerase activity: A systematic review and meta-analysis. Mindfulness, 14(3), 495–509. https://doi.org/10.1007/s12671-023-02075-x

11. Siew, S., & Yu, J. (2025). Retraction note: Mindfulness-based randomized controlled trials led to brain structural changes: An anatomical likelihood meta-analysis. Scientific Reports, 15, 25545. https://doi.org/10.1038/s41598-025-11069-9 (Retraction of: Scientific Reports, 13, 18469, 2023. https://doi.org/10.1038/s41598-023-45765-1)

12. Farias, M., Maraldi, E., Wallenkampf, K. C., & Lucchetti, G. (2020). Adverse events in meditation practices and meditation-based therapies: A systematic review. Acta Psychiatrica Scandinavica, 142(5), 374–393. https://doi.org/10.1111/acps.13225

13. Hirshberg, M. J., Goldberg, S. B., Rosenkranz, M., & Davidson, R. J. (2022). Prevalence of harm in mindfulness-based stress reduction. Psychological Medicine, 52(6), 1080–1088. https://doi.org/10.1017/S0033291720002834